Immune Profiling for Cancer Immunotherapy Response

Clinical trial NCT06116032 · RECRUITING

Trial details

NCT number: NCT06116032
Sponsor: Dartmouth-Hitchcock Medical Center
Status: RECRUITING
Study type: OBSERVATIONAL

Cancer Tumor, Solid Hematologic Malignancy Blood Cancer

Start date: 2022-10-03
Primary completion: 2027-01-01
Enrollment: 1500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.